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HE immune system has traditionally been di-
vided into innate and adaptive components,
each with a different function and role. The
adaptive component is organized around two classes
of specialized cells, T cells and B cells. Since each lym-
phocyte displays a single kind of structurally unique
receptor, the repertoire of antigen receptors in the
entire population of lymphocytes is very large and
extremely diverse. The size and diversity of this rep-
ertoire increase the probability that an individual lym-
phocyte will encounter an antigen that binds to its
receptor, thereby triggering activation and prolifera-
tion of the cell. This process, termed clonal selec-
tion, accounts for most of the basic properties of the
adaptive immune system.
Clonal expansion of lymphocytes in response to
infection is absolutely necessary for the generation
of an efficient immune response. However, it takes
three to five days for sufficient numbers of clones to
be produced and to differentiate into effector cells,
which allows more than enough time for most patho-
gens to damage the host. In contrast, the effector
mechanisms of innate immunity, which include an-
timicrobial peptides, phagocytes, and the alternative
complement pathway, are activated immediately after
infection and rapidly control the replication of the
infecting pathogen. For this reason, containing the in-
fection until the lymphocytes can begin to deal with
it has long been considered the main function of in-
nate immunity. However, it has become increasingly
clear that the innate immune system has a much more
important and fundamental role in host defense. In
this article we will outline the ways in which the in-
nate immune system interacts with and controls adap-
tive immune responses.
The clinical implications of these discoveries are just
T
 
beginning to emerge, and we expect them to con-
tribute in important ways to our understanding of
the body’s defense against bacteria, the way in which
the adaptive immune system establishes long-lasting
antimicrobial protection, and some of the mechanisms
used to avoid producing autoimmunity.
 
STRATEGIES OF INNATE AND ADAPTIVE 
IMMUNE RECOGNITION
 
The main distinction between the innate and the
adaptive immune systems lies in the mechanisms and
receptors used for the immune recognition. In the
adaptive immune system, the T-cell receptor and the
B-cell receptor are generated somatically, during
the development of T and B cells, in a way that en-
dows each lymphocyte with a structurally unique re-
ceptor. Since these receptors are not encoded in the
germ line, they are not predestined to recognize any
particular antigen. Rather, an extremely diverse reper-
toire of receptors is generated randomly, and lympho-
cytes bearing useful receptors (i.e., receptors specific
for pathogens) are subsequently selected for clonal
expansion by encountering the antigens for which
they happen to be specific. These useful receptors,
moreover, cannot be passed on to the next generation,
even though they might give one’s progeny a surviv-
al advantage. No matter how beneficial they may be,
antigen receptors for common environmental patho-
gens have to be reinvented by every generation.
Since the binding sites of antigen receptors arise
as a result of random genetic mechanisms, the recep-
tor repertoire contains binding sites that can react
not only with infectious microorganisms but also with
innocuous environmental antigens and self antigens.
Activation of the adaptive immune response can be
harmful to the host when the antigens are self or en-
vironmental antigens, since immune responses to such
antigens can lead to autoimmune diseases and aller-
gies. How does the immune system determine the
origin of the antigen, and how does it decide whether
to induce an immune response? Recent studies dem-
onstrate that the innate immune system has a major
role in these decisions.
During evolution, the innate immune system ap-
peared before the adaptive immune system, and some
form of innate immunity probably exists in all mul-
ticellular organisms. By contrast with adaptive im-
munity, innate immune recognition is mediated by
germ-line–encoded receptors, which means that the
specificity of each receptor is genetically predeter-
mined. One advantage of these germ-line–encoded
receptors is that they evolved by natural selection to










isms. The problem is, however, that every organism
has a limit to the number of genes it can encode in
its genome. The human genome, for example, con-
tains only 75,000 to 100,000 genes, most of which
have nothing to do with immune recognition. By








different somatically generated immunoglobulin re-
ceptors and T-cell receptors, respectively. The total
number of receptors involved in innate immune rec-
ognition is thought to be in the hundreds. More-
over, microbes are extremely heterogeneous and can
mutate at a much higher rate than any of their hosts.
The strategy of the innate immune response may
not be to recognize every possible antigen, but rather
to focus on a few, highly conserved structures present





are referred to as pathogen-associated molecular pat-
terns, and the receptors of the innate immune sys-
tem that evolved to recognize them are called pat-
tern-recognition receptors. The best-known examples
of pathogen-associated molecular patterns are bacteri-
al lipopolysaccharide, peptidoglycan, lipoteichoic ac-
ids, mannans, bacterial DNA, double-stranded RNA,
and glucans. Although these structures are chemically
quite distinct, all pathogen-associated molecular pat-





ated molecular patterns are produced only by micro-
bial pathogens, and not by their hosts. For example,
lipopolysaccharide is synthesized only by bacteria;
pattern-recognition receptors recognize lipopolysac-
charide, thus alerting the host to the presence of the
infecting organism. Second, the structures recognized
by the innate immune system are usually essential
for the survival or pathogenicity of microorganisms.
Third, pathogen-associated molecular patterns are
usually invariant structures shared by entire classes of
pathogens. For example, all gram-negative bacteria
have lipopolysaccharides, and therefore, the lipopoly-
saccharide pattern-recognition receptor of the host





The receptors of the innate immune system that
are encoded in the germ line differ from antigen re-
ceptors in several important ways. They are expressed
on many effector cells of the innate immune system,
most importantly on macrophages, dendritic cells, and
B cells — the professional antigen-presenting cells.
The expression of pattern-recognition receptors is
not clonal, in that all such receptors displayed by cells
of a given type (e.g., macrophages) have identical spec-
ificities. Moreover, once the pattern-recognition re-
ceptors identify a pathogen-associated molecular pat-
tern, the effector cells are triggered to perform their
effector functions immediately rather than after they
have proliferated. This fact accounts for the rapid ki-
netics of innate immune responses.
Structurally, pattern-recognition receptors belong
to several families of proteins. Leucine-rich repeat do-
mains, calcium-dependent lectin domains, and scaven-
ger-receptor protein domains, for example, are often





tern-recognition receptors can be divided into three
classes: secreted, endocytic, and signaling. Secreted
pattern-recognition molecules function as opsonins
by binding to microbial cell walls and flagging them
for recognition by the complement system and phag-
ocytes.





 a member of the calcium-
dependent lectin family that binds to microbial car-
bohydrates to initiate the lectin pathway of comple-
ment activation. Mannan-binding lectin and surfactant
proteins form a structurally related family of collec-
tins, so named because they consist of a collagenous
domain linked to the calcium-dependent lectin do-
main. Mannan-binding lectin is synthesized in the
liver and is secreted into the serum as a component
of the acute-phase response. It can bind to carbohy-
drates on gram-positive and gram-negative bacteria





nan-binding lectin is associated with two serine pro-
teases, mannan-binding lectin–associated proteases
1 and 2. These proteases are related to C1r and C1s,
the serine proteases of the classic complement path-
way. Similar to C1r and C1s, mannan-binding lectin–
associated protease, once activated, ultimately leads
to the cleavage of the third component of comple-
ment (C3) and to the activation of C3 convertase,





 However, unlike C1 proteases, which re-
quire antigen–antibody complexes for their activa-
tion, mannan-binding lectin–associated proteases are
activated by the binding of microbial ligands to man-
nan-binding lectin (Fig. 1).
Endocytic pattern-recognition receptors occur on
the surface of phagocytes. On recognizing pathogen-
associated molecular patterns on a microbial cell,
these receptors mediate the uptake and delivery of
the pathogen into lysosomes, where it is destroyed.
Pathogen-derived proteins can then be processed,
and the resulting peptide can be presented by major-
histocompatibility-complex (MHC) molecules on the
surface of the macrophage.
The macrophage mannose receptor, which is also
a member of the calcium-dependent lectin family, is
an endocytic pattern-recognition receptor. It specif-
ically recognizes the carbohydrates with large numbers
of mannoses that are characteristic of microorganisms




Another endocytic pattern-recognition receptor, the
macrophage scavenger receptor, binds to bacterial cell
walls and is an essential part of the clearance of
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molecular patterns and activate signal-transduction
pathways that induce the expression of a variety of
immune-response genes, including inflammatory cy-
tokines. The recently identified receptors of the toll
family appear to have a major role in the induction of




The first receptor of the toll family was identified
in drosophila as a component of a signaling pathway








 gene revealed that
it encodes a transmembrane protein with a large ex-
tracellular domain containing leucine-rich repeats. Re-
markably, the sequence of the cytoplasmic domain of
the toll protein turned out to be similar to the cyto-





 Moreover, both the interleukin-1 receptor in
humans and toll in drosophila induce signal-trans-
duction pathways that lead to the activation of tran-













 Members of this family have a key role in the





 In drosophila, microbial infection triggers





 Interestingly, the promoter re-
gions of the genes encoding these peptides, like many
mammalian genes involved in inflammation and im-





These findings suggested that drosophila toll, in
addition to its role in embryonic development, is in-
volved in the immune responses of adult flies. This










 gene were shown to be highly susceptible
to fungal infection. Interestingly, however, inactiva-




 gene did not impair responsiveness to





 other members of the toll family
may be programmed to recognize bacterial pathogens
and induce antibacterial responses.
Homologues of drosophila toll have been identi-





 The first human toll to be char-
acterized (now referred to as toll-like receptor 4, or
TLR4) was shown to induce, like its drosophila hom-





ing pathway. Through this pathway, the activation of
TLR4 induces the expression of a variety of cytokines





 These findings suggested





 This is now known to be the case
for at least two members of the toll family, TLR4
and TLR2.
The first evidence linking TLR4 to the innate im-
mune system was the demonstration that it is the




 The Lectin Pathway of Complement Activation.
Activation of the lectin pathway of complement is mediated by
mannose-binding lectin, which is a pattern-recognition recep-
tor specific for microbial carbohydrates. Mannose-binding lec-
tin is associated with the serine proteases mannan-binding lec-
tin–associated proteases 1 and 2 (MASP1 and MASP2). Binding
of mannose-binding lectin to its microbial ligands activates
these proteases, which leads to the cleavage of the comple-
ment components C2 and C4. The cleavage products C2a and
C4b then form a C3 convertase, which initiates the complement
cascade by cleaving the C3 protein. The complex of mannose-
binding lectin and its proteases functions similarly to the C1
complex of the classic complement cascade. It is important to
note, however, that the C1r and C1s serine proteases are acti-
vated by the binding of C1q to the antibody–antigen complex
and are thus dependent on antibody responses, whereas acti-
vation of the complement pathway is triggered directly by mi-

































or a targeted disruption of the gene have no response





 By contrast, mice with a targeted









 It is therefore clear that TLR4,
but not TLR2, is essential for the recognition of lipo-
polysaccharide.
TLR4 is not the only protein involved in the rec-
ognition of lipopolysaccharide, however. Lipopoly-
saccharide first interacts with a serum protein called
lipopolysaccharide-binding protein, which transfers
lipopolysaccharide to CD14, a receptor on macro-
phages and B cells that is anchored to the cell surface










 making it likely that
the lipopolysaccharide-recognition complex has at
least three components — CD14, TLR4, and MD-2.
TLR4 and MD-2 are constitutively associated with
each other, whereas CD14 is presumably recruited to
the complex after binding lipopolysaccharide (Fig. 2).




 gene is deleted have no
response to two major bacterial pathogen-associat-





 Since at least 10 mammalian TLRs have
been identified, some if not all of them are probably
involved in the recognition of the major microbial
patterns that trigger innate immune responses. It is





profoundly affect the immune system. The strain of





 gene, for example, is highly susceptible to
gram-negative bacterial infections. Conceivably, poly-




 gene are correlated
with an increased susceptibility to gram-negative in-
fection.





 genes is still very limited, mutations in both
the ectodomains and the cytoplasmic domains of




 It remains to be seen
whether these mutations affect TLR4-mediated rec-
ognition of lipopolysaccharides and susceptibility to
infection.
 
INNATE IMMUNE RECOGNITION 
AND CONTROL OF ADAPTIVE
IMMUNE RESPONSES
 
As discussed earlier, the adaptive immune system
has a tremendous capacity to recognize almost any
antigenic structure, but because antigen receptors are
generated at random, they bind to antigens regard-
less of their origin — bacterial, environmental, or self.
The receptors of the innate immune system, by con-
trast, are specific for structures found exclusively in
microbial pathogens (pathogen-associated molecular
patterns), which is why they function to signal the




 The Signaling Pathway of Toll-like Receptors.
Some of the toll-like receptors (TLRs) function as pattern-rec-
ognition receptors of the innate immune system. Their recog-









B) signaling pathway. In this example, the
recognition of lipopolysaccharide is mediated by three differ-
ent gene products: CD14, toll-like receptor 4 (TLR4), and MD-2.
The binding of lipopolysaccharide to CD14 presumably leads to
the association of CD14 with the TLR4–MD-2 complex and is
thought to induce the dimerization of TLR4. Once TLR4 is acti-
vated, it recruits the adapter protein MyD88, which is associat-
ed with the serine–threonine protein kinase interleukin-1 re-
ceptor–associated kinase (IRAK). IRAK is then phosphorylated
and associated with the tumor necrosis factor–associated fac-
tor 6 (TRAF-6) adapter protein. Oligomerization of TRAF-6 is
thought to activate a member of the mitogen-activated protein
kinase kinase kinase (MAP3K) family, which directly or indirect-























moves into the nucleus and induces the transcriptional activa-
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tion by the innate immune system, in turn, control the
activation of adaptive immune responses; the adap-
tive immune system responds to a pathogen only after
it has been recognized by the innate immune system.
For example, T cells use their antigen receptors to
recognize a ligand in the form of a peptide bound
to an MHC class II molecule on the surface of an
antigen-presenting cell. However, these peptides can
be either self peptides or peptides derived from a mi-
crobial pathogen. And because the antigen receptor
was randomly generated, the T cell cannot distinguish
self from nonself on the basis of peptide recognition
alone. Indeed, the recognition of the peptide–MHC
ligand by the antigen receptor is not sufficient to ac-
tivate T cells. T cells require at least two signals to
become activated: one is the complex of a peptide
and an MHC molecule, and the other is a costimu-
latory signal mediated by, for example, the CD80
and CD86 molecules on the surface of the antigen-
presenting cell. It is only when the antigen-present-
ing cell expresses both antigen and CD80 or CD86
molecules that the T cell can be activated. Recogni-
tion of an antigen in the absence of CD80 or CD86
molecules leads to permanent inactivation or apop-
tosis of the T cell.
The expression of CD80 and CD86 molecules on
the surface of the antigen-presenting cell is con-
trolled by the innate immune system. Receptors such
as TLRs induce these molecules to appear on the an-
tigen-presenting cell when they recognize their cog-





pathogen-associated molecular patterns occur only
on pathogens, TLRs induce CD80 and CD86 mol-
ecules only in the presence of infection. A T cell, in
turn, receives both of the signals required for activa-
tion only if its receptor binds to the peptide that was
derived from the pathogen that induced the expression
of CD80 or CD86 molecules through its pathogen-





 The Receptors Involved in the Interplay of the Innate and Adaptive Immune Systems.
Recognition of the pathogen-associated molecular pattern (PAMP) by pattern-recognition receptors, such as the toll-like receptors,
generates signals that activate the adaptive immune system. Endocytic pattern-recognition receptors, such as the macrophage man-
nose receptor, bind to components of microbial cell walls and mediate the uptake and phagocytosis of pathogens by antigen-pre-
senting cells (macrophages and dendritic cells). Proteins derived from the microorganisms are processed in the lysosomes to gen-
erate antigenic peptides, which form a complex with major-histocompatibility-complex (MHC) class II molecules on the surface of
the macrophage. These peptides are recognized by T-cell receptors. In the case of the signaling class of pattern-recognition receptors,
the recognition of pathogen-associated molecular patterns by toll-like receptors leads to the activation of signaling pathways that
induce the expression of cytokines, chemokines, and costimulatory molecules. Therefore, pattern-recognition receptors have a role




























Self antigens, on the other hand, are not recog-
nized by receptors of the innate immune system and,
therefore, do not induce the expression of CD80 or
CD86 molecules. This mechanism ensures that, nor-
mally, only pathogen-specific T cells are activated.
After activation, helper T cells control other compo-
nents of adaptive immunity, such as the activation of
cytotoxic T cells, B cells, and macrophages. Innate
immune recognition therefore appears to control all
the major aspects of the adaptive immune responses
through the recognition of infectious microbes and
the induction of signals required for the triggering
of adaptive immunity.
 
INNATE IMMUNITY AND DISEASE
 
Given the essential role of the innate immune sys-
tem in regulating all aspects of immunity, it is con-
ceivable that dysfunction of the components of in-
nate immunity can contribute to diseases. Two general
types of genetic alterations could lead to immuno-
logic abnormalities: mutations that inactivate the re-
ceptors or signaling molecules involved in innate im-
mune recognition and mutations that render them
constitutively active.
The first type of mutation would be expected to
result in various types of immunodeficiencies. The
second type of mutation would trigger inflammato-
ry reactions and could thus contribute to a wide va-
riety of conditions with an inflammatory component,
including asthma, allergy, arthritis, and autoimmu-
nity. Indeed, mutations in macrophage mannose re-
ceptors and mannan-binding lectin of both humans
and mice have been associated with increased sus-













is likely to provide new insights into the cause of im-
mune and inflammatory disorders. A dramatic example
of the effect of mutational inactivation of an unknown
component in the toll and interleukin-1 receptor sig-
naling pathways was described recently in a patient






Innate immunity, an ancient form of host defense,
must have appeared early in the evolution of multi-
cellular organisms, because many genes involved in
innate host defense occur not only in vertebrate and
invertebrate animals but also in plants. Higher-order
vertebrates also have an adaptive immune system
whose principles of operation are quite different from
those of innate immunity. The random generation
of a highly diverse repertoire of antigen receptors al-
lows the adaptive immune system to recognize vir-
tually any antigen. But the price of this diversity is
the inability to distinguish foreign antigens from self
antigens. The innate immune system, by contrast,
deploys a limited number of receptors with specific-
ity for conserved microbial structures. Recognition of
these structures by the innate immune system induc-
es costimulators, cytokines, and chemokines, which
recruit and activate antigen-specific lymphocytes and
initiate adaptive immune responses.
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